Data from Médecine Intensive Réanimation - Curated by EPG Health - Date available 03 November 2017
Availability
Free full text
Original date published
3 November 2017
Original format
Print publication
Fulminant myocarditis is a rare inflammatory affecting relatively young adult. We report a case of 29-year-old pregnant woman with an acute intraoperative onset of a severe heart failure. A rapid and accurate diagnostic approach suggested an acute fulminant myocarditis. Initial hemodynamic support without immunosuppressive and viral therapy resulted in a partial recovery within a two week. Patients presenting with acute fulminant myocarditis with unknown etiology can have a complete recovery with an appropriate and rapid timing of an aggressive hemodynamic support including levosimendan and extracorporeal membrane oxygenation.
(Article in French)
Data sources
Read abstract on library site Access full article
Learning Zones
An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.
Acute and Advanced Heart Failure
What are the most effective treatments for acute heart failure? Can you define advanced heart failure? Discover here...
+ 3 more
Fabry Disease
Explore the pathophysiology and treatment options for Fabry disease, a deficiency of the lysosomal enzyme alpha-galactosidase A
Transplantation
See information on best practice in solid organ transplantation, and expert discussions on related hot topics.
Related Content
FDA approves AngelMed Guardian System to detect acute coronary syndrome events.- Angel Medical Systems.
Angel Medical Systems, Inc. has received FDA premarket approval (PMA) for the ‘AngelMed Guardian System’. The AngelMed Guardian System is...
Added 2 days ago
Sub analysis of PEGASUS-TIMI 54 study shows risk reduction with use of Brilinta in heart attack survivors.-AstraZeneca
AstraZeneca announced results from a new sub-analysis of the Phase III PEGASUS-TIMI 54 trial, demonstrating a risk reduction of 19%...
Added 2 months ago
Are standard medical tests good enough to diagnose heart attacks?
Study reveals the danger of poor diagnosis, which may lead to two-thirds of heart attacks being missed.
Added 2 months ago
Magnetic nanoparticles could help rejuvenate damaged hearts
An interdisciplinary team has been investigating a new approach using replacement cells that contain magnetic nanoparticles, allowing them to be held in place.
Added 4 months ago
Xarelto found to improve patient outcomes with PAD and CAD
COMPASS trial showed that Xarelto (rivaroxaban) from Bayer and Janssen significantly cut the amputation rate for patients with peripheral artery disease (PAD) and a 23% reduction in deaths in patients with coronary artery disease (CAD).
Added 5 months ago
Comments
You will need to login, to leave a comment.
epgonline.org is not monitored for collection of adverse event reports. Any adverse events should be reported to your national reporting agency and/or the manufacturer.